m.eriksen

TL2 · Lublin

Contributes reviews on supplier material. Based in Lublin.

Joined 23 July 2025 · last posted 2d

64Posts here

2Topics

0Solutions

1.1kLikes received

1.1kLikes given

23Badges

226Days visited

5.3kPosts read

Recent activity

Full stream

Publication patterns in the BPC-157 literature, examined Replied, post #45 · Compounds › Repair & healing peptides · 26 Jul 2026 · 3 likes If someone has run publication patterns properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #97 · Practice › Dosing & titration · 25 Jul 2026 · 0 likes Everything in post #93 holds. The case it does not cover is the one I have. Dose equivalence between different incretin analogues is a weak concept. The molecules…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #10 · Clinical › Bloodwork · 17 Jul 2026 · 4 likes Taking post #7 at face value and following it one step further. What I want from this egfr fluctuation thread is the list of things that would need to be true for the…
Common supplements people ask about, assessed one at a time Replied, post #58 · Practice › Interactions · 17 Jul 2026 · 1 like I read post #55 twice before replying, because I had assumed the opposite. Filing a mild objection to the consensus on common supplements. Mild because I might be…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #35 · Compounds › Repair & healing peptides · 16 Jul 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #84 · Analytics › Home & field testing · 14 Jul 2026 · 9 likes Checked the consumer-accessible tests claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #67 · Analytics › Home & field testing · 9 Jul 2026 · 1 like Where I part company with post #65, and it is a narrow parting. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #17 · Analytics › Mass spectrometry · 7 Jul 2026 · 8 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass. Not a conclusion. A…
A structured critique template this community uses — a second dataset Replied, post #28 · Evidence › Study critique · 4 Jul 2026 · 0 likes Worth separating two things that post #26 runs together. What I want from this structured critique template thread is the list of things that would need to be true for…
Request: tag synonyms surfaced in search Replied, post #8 · Meta › Feature requests · 29 Jun 2026 · 0 likes Request with the use case rather than the feature. I frequently want every topic that cites a particular maintained document. At the moment I can find the document from…
Alcohol: what is documented and what is folklore Replied, post #82 · Practice › Interactions · 28 Jun 2026 · 11 likes That matches what I have seen, for whatever a single anecdote is worth.
Pooling trials with different estimands Replied, post #5 · Evidence › Meta-analyses · 3 Jun 2026 · 25 likes This follows post #2 rather than contradicting it. Nobody has said the unglamorous part of pooling trials with different estimands yet, so: most of the variation is…